Ontology highlight
ABSTRACT: Background
Patients with type 2 diabetes (T2DM) often have poor glycemic control on first-line pharmacologic therapy and require treatment intensification. Intensification decisions can be difficult because of many available options and their many benefits and risks. The American Diabetes Association recommends patient-centered, evidence-based tools supporting shared decision-making between patients and clinicians. We developed a patient decision aid (PDA) targeting decisions about treatment intensification for T2DM. Our objective was to determine the effectiveness of this PDA for patients with T2DM on metformin who require treatment intensification.Methods
This study was a pragmatic randomized controlled trial conducted in 27 US primary care and endocrinology clinics. Subj
SUBMITTER: Bailey RA
PROVIDER: S-EPMC4712511 | biostudies-literature | 2016 Jan
REPOSITORIES: biostudies-literature